skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I hold the common shares of BK & PVD the split product issued by Quadravest and have been happy for about 12 years even when they suspended pay out for a while.
I would like to know your take on their preferreds. BK.PR.A & PVD.PR.A as to their distribution safety compared to their underlining assets ( banks and insurance companies). Would you advise holding or buy some of the preferred or would see holding a bank ETF as better. Your overall view of the above would be appreciated.

Thanks
Yossi
Read Answer Asked by JOSEPH on February 07, 2019
Q: About a year ago, someone asked you about a new ETF, BHAV, which buys or shorts stocks that are mispriced for various reasons ("New ETF leverages emotional sell-offs" was a Financial Post headline). At the time, you replied that the fund was too new, and to check again in a year. I wonder if you can comment any further on it now (I've not been able to find out much of anything about it).
Read Answer Asked by chris on February 07, 2019
Q: At the current share price of around Can $3.50 CPG has an enterprise value of about 6 billion ($4 billion in debt and $2 billion in equity). CPG produces about 175,000 boe per day so that means it trade at around Can $34,000 flowing barrel. Isn't that an extremely cheap valuation? If so, could that cheap valuation attract a takeover offer. Even at a 50 per cent premium CPG is trading at a cheap price on a flowing barrel metric. Or is there such a lack of interest in the Canadian oil patch that no body cares that it trades cheaply?
Read Answer Asked by Paul on February 07, 2019
Q: Hi 5I.
What is your take on these stocks? Debt level and earnings? Next reporting? Growth potential?
Are they worth keeping?
I bought FSZ for income. Is income safe?
Many thanks,
Dick
Read Answer Asked by Richard on February 07, 2019
Q: As much as I enjoy your service, there are times when I find your answers provide insufficient depth. I can understand that when you are asked about obscure companies that most of us have never heard of, but I do expect more, perhaps incorrectly, when the question pertains to companies in your portfolios. Case in point on Feb 6 a question asked what you would recommend , GSY or ECN. Your answer without any support was GSY with no rationale for your choice
On Feb 5, ECN held an information session that provided guidance for 2019.
Management are looking at EPS of 23-25 cents . up from about 11 cents in 2018.
Key sub components are looking quite strong:

Kessler's projections imply earnings growth of close to 40% and revenue growth of around 60%.
Triad is guiding for adjusted operating income to grow around 17%
SFC guidance is for adjusted operating income to grow around 25% in 2019. Originations guidance is expected to be up around 36%. Management believes that the business can grow about 20% annually going forward.
Without getting into them there are other numbers that I have not mentioned that also look quite strong..
The company has been in a transitional phase the last couple of years and there will be some potential losses as ECN sells some of its legacy assets. All in all, it would appear that guidance was extremely positive.
So given this outlook what is it about GSY that makes it a better choice?


Read Answer Asked by John on February 07, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!